Citation: | Fan Lianhui, Liu Long, He Long, et al. Analysis of relationship between aldosterone level changes and renal function during perioperative period of renal transplantation[J]. ORGAN TRANSPLANTATION, 2016, 7(2): 128-131. doi: 10.3969/j.issn.1674-7445.2016.02.010 |
[1] |
Rezaee-Zavareh MS, Ajudani R, Ramezani Binabaj M, et al. Kidney allograft stone after kidney transplantation and its association with graft survival[J]. Int J Organ Transplant Med, 2015, 6(3):114-118. http://www.ncbi.nlm.nih.gov/pubmed/26306157
|
[2] |
Asher J, Vasdev N, Wyrley-Birch H, et al. A prospective randomised paired trial of sirolimus versus tacrolimus as primary immunosuppression following non-heart beating donor kidney transplantation[J]. Curr Urol, 2014, 7(4):174-180. https://www.ncbi.nlm.nih.gov/pubmed/26195946
|
[3] |
苏子庭, 李珍, 曾仲, 等.活体肾移植供肾肾小球滤过率对术后移植肾功能恢复的影响[J].器官移植, 2015, 6(5):331-334, 339. http://www.organtranspl.com/browse/detail/qkid/32/id/129.html
Su ZT, Li Z, Zeng Z, et al. Influence of glomerular filtration rate of living donor on recovery of graft function after transplantation[J]. Organ Transplant, 2015, 6(5):331-334, 339. http://www.organtranspl.com/browse/detail/qkid/32/id/129.html
|
[4] |
Te Riet L, van Esch JH, Roks AJ, et al. Hypertension:renin-angiotensin-aldosterone system alterations[J].Circ Res, 2015, 116(6):960-975. doi: 10.1161/CIRCRESAHA.116.303587
|
[5] |
Singh P, Feld RI, Colombe BW, et al. Sensitization, pathologic, and imaging findings comparing symptomatic and quiescent failed renal allografts[J]. Clin Transplant, 2014, 28(12):1424-1432. doi: 10.1111/ctr.2014.28.issue-12
|
[6] |
Daniel C, Vogelbacher R, Stief A, et al. Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis inchronic allograft nephropathy[J]. PLoS One, 2013, 8(12):e83846. doi: 10.1371/journal.pone.0083846
|
[7] |
Sandhu JS, Kansal S, Bajwa GS, et al. Ocular changes in renal allograft recipients and patients of chronic kidney disease[J]. Saudi J Kidney Dis Transpl, 2014, 25(6):1285-1289. doi: 10.4103/1319-2442.144269
|
[8] |
Vaidya A, Underwood PC, Hopkins PN, et al. Abnormal aldosterone physiology and cardiometabolic risk factors[J]. Hypertension, 2013, 61(4):886-893. doi: 10.1161/HYPERTENSIONAHA.111.00662
|
[9] |
Bollag WB. Regulation of aldosterone synthesis and secretion[J]. Compr Physiol, 2014, 4(3):1017-1055.
|
[10] |
Hart A, Jackson S, Kasiske BL, et al. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy:post hoc analysis from the angiotensin Ⅱ blockade in chronic allograft nephropathy trial[J]. Transplantation, 2014, 97(10):1066-1071. doi: 10.1097/01.TP.0000440952.29757.66
|
[11] |
Bernardi S, Toffoli B, Zennaro C, et al. Aldosterone effects on glomerular structure and function[J]. J Renin Angiotensin Aldosterone Syst, 2015, 16(4):730-738. doi: 10.1177/1470320315595568
|
[12] |
范愈燕, 孙永新, 支楠, 等.醛固酮诱导大鼠肾脏衰老机制研究[J].中国临床药理学杂志, 2013, 29(1):42-44. http://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201301014.htm
Fan YY, Sun YX, Zhi N, et al. Mechanism of aldosterone induced rat kidney senescence[J]. Chin J Clin Pharmacol, 2013, 29(1):42-44. http://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201301014.htm
|
[13] |
Hsu TW, Liu JS, Hung SC, et al. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia[J]. JAMA Intern Med, 2014, 174(3):347-354. doi: 10.1001/jamainternmed.2013.12700
|
[14] |
Mavrakanas TA, Gariani K, Martin PY. Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitoror angiotensin Ⅱ receptor blocker treatment:an emerging paradigm in diabetic nephropathy:a systematic review[J]. Eur J Intern Med, 2014, 25(2):173-176. doi: 10.1016/j.ejim.2013.11.007
|
[15] |
BarıŞ N, Özpelit E, Doğan NB, et al. The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients[corrected][J]. Anadolu Kardiyol Derg, 2013, 13(3):245-250. https://www.ncbi.nlm.nih.gov/pubmed/23261803
|
[16] |
Peng F, Su J, Lin J, et al. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury:a prospective study and meta-analysis[J]. J Cardiovasc Pharmacol, 2015, 65(3):262-268. doi: 10.1097/FJC.0000000000000189
|
[17] |
Huang LL, Nikolic-Paterson DJ, Ma FY, et al. Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K/MAPK signaling[J]. Nephron Exp Nephrol, 2012, 120(4):e115-e122. doi: 10.1159/000339500
|